[
  {
    "headline": "3 Cheap Stocks to Buy With Your Tax Refund Check",
    "url": "https://www.fool.com/investing/2025/03/07/3-cheap-stocks-to-buy-with-your-tax-refund-check/?source=eptyholnk0000202&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=e6df05ff-087d-4267-aca1-d4ad92d13f2a&.tsrc=rss",
    "publication_date": "No publication date found",
    "full_article_text": "No content found"
  },
  {
    "headline": "2 Dividend Stocks to Buy for a Lifetime of Passive Income",
    "url": "https://www.fool.com/investing/2025/03/07/2-dividend-stocks-to-buy-for-a-lifetime-of-passive/?source=eptyholnk0000202&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=46ffd06e-ff16-4cd9-b321-173a6e9418b4&.tsrc=rss",
    "publication_date": "No publication date found",
    "full_article_text": "No content found"
  },
  {
    "headline": "Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out",
    "url": "https://finance.yahoo.com/m/32d0d7c8-0bd1-33f4-8155-c5cc92624c9b/johnson-%26-johnson-and-4-other.html?.tsrc=rss",
    "publication_date": "2025-03-05T20:39:00.000Z",
    "full_article_text": "No content found"
  },
  {
    "title": "Antibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020\u20132034) as New Innovations Drive Therapy Advancements | DelveInsight",
    "url": "https://www.globenewswire.com/news-release/2025/02/20/3029945/0/en/Antibody-Drug-Conjugates-Market-to-Witness-Rapid-Growth-Across-7MM-During-the-Study-Period-2020-2034-as-New-Innovations-Drive-Therapy-Advancements-DelveInsight.html",
    "date": "2025-02-20 18:00:00"
  },
  {
    "title": "Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight",
    "url": "https://www.globenewswire.com/news-release/2025/02/13/3026190/0/en/Alpha-Synuclein-Inhibitors-Clinical-Trial-Pipeline-as-Novel-and-Extensive-22-Therapies-Likely-to-Enter-in-the-Domain-DelveInsight.html",
    "date": "2025-02-13 18:00:00"
  },
  {
    "title": "AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies",
    "url": "https://www.globenewswire.com/news-release/2025/02/12/3024949/0/en/AbbVie-and-Xilio-Therapeutics-Announce-Collaboration-and-Option-Agreement-to-Develop-Novel-Tumor-Activated-Immunotherapies.html",
    "date": "2025-02-12 12:33:00"
  }
]